Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference
Evolus (NASDAQ: EOLS), a performance beauty company focused on building an aesthetic portfolio, has announced its upcoming participation in the Needham 24th Annual Virtual Healthcare Conference.
The company's management team will engage in a fireside chat scheduled for Tuesday, April 8, 2025, at 12:45 PM ET on Track 1, alongside investor meetings. Interested parties can access the fireside chat through the Investor Relations section of the Evolus website, with the webcast replay remaining available for 90 days following the presentation.
Evolus (NASDAQ: EOLS), un'azienda di bellezza focalizzata sulle performance e sulla costruzione di un portfolio estetico, ha annunciato la sua prossima partecipazione alla 24ª Conferenza Sanitaria Virtuale Annuale di Needham.
Il team di gestione dell'azienda parteciperà a una chiacchierata informale programmata per martedì 8 aprile 2025, alle 12:45 PM ET su Track 1, insieme a incontri con gli investitori. Le parti interessate possono accedere alla chiacchierata informale attraverso la sezione Relazioni con gli Investitori del sito web di Evolus, con la registrazione del webcast disponibile per 90 giorni dopo la presentazione.
Evolus (NASDAQ: EOLS), una empresa de belleza enfocada en el rendimiento y en construir un portafolio estético, ha anunciado su próxima participación en la 24ª Conferencia Virtual Anual de Salud de Needham.
El equipo de gestión de la empresa participará en una charla informal programada para martes 8 de abril de 2025, a las 12:45 PM ET en Track 1, junto con reuniones con inversores. Las partes interesadas pueden acceder a la charla informal a través de la sección de Relaciones con Inversores en el sitio web de Evolus, con la repetición del webcast disponible durante 90 días después de la presentación.
에볼루스 (NASDAQ: EOLS), 성과 중심의 뷰티 회사로 미적 포트폴리오 구축에 집중하고 있는 에볼루스는 니드햄 제24회 연례 가상 의료 회의에 참여할 예정이라고 발표했습니다.
회사의 경영진은 2025년 4월 8일 화요일, 동부 시간 기준 오후 12시 45분에 Track 1에서 투자자 회의와 함께 예정된 파이어사이드 챗에 참여할 것입니다. 관심 있는 분들은 에볼루스 웹사이트의 투자자 관계 섹션을 통해 파이어사이드 챗에 접근할 수 있으며, 프레젠테이션 후 90일 동안 웹캐스트 재생이 가능합니다.
Evolus (NASDAQ: EOLS), une entreprise de beauté axée sur la performance et la construction d'un portefeuille esthétique, a annoncé sa prochaine participation à la 24ème Conférence Annuelle Virtuelle de Santé de Needham.
L'équipe de direction de l'entreprise participera à une discussion informelle prévue pour mardi 8 avril 2025, à 12h45 ET sur Track 1, ainsi qu'à des réunions avec des investisseurs. Les parties intéressées peuvent accéder à la discussion informelle via la section Relations Investisseurs du site web d'Evolus, avec la rediffusion du webcast disponible pendant 90 jours suivant la présentation.
Evolus (NASDAQ: EOLS), ein leistungsorientiertes Beauty-Unternehmen, das sich auf den Aufbau eines ästhetischen Portfolios konzentriert, hat seine bevorstehende Teilnahme an der 24. jährlichen virtuellen Gesundheitskonferenz von Needham angekündigt.
Das Management-Team des Unternehmens wird an einem geplanten Fireside-Chat teilnehmen, der für Dienstag, den 8. April 2025, um 12:45 Uhr ET auf Track 1 angesetzt ist, zusammen mit Investoren-Meetings. Interessierte können über den Bereich Investor Relations auf der Evolus-Website auf den Fireside-Chat zugreifen, wobei die Webcast-Wiedergabe 90 Tage nach der Präsentation verfügbar bleibt.
- None.
- None.
The fireside chat will take place on Tuesday, April 8, 2025, at 12:45 PM ET - Track 1.
The fireside chats can be accessed on the Investor Relations page of the Evolus website here. A replay of the webcast will be available for 90 days after the date of each presentation.
About Evolus, Inc.
Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse™, a collection of unique injectable hyaluronic acid (HA) gels. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.
Jeuveau® and Nuceiva®, are registered trademarks and Evolysse™ is a trademark of Evolus, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250325705006/en/
Investors:
Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications
Phone: (248) 202-9267
Email: ir@evolus.com
Media:
Email: media@evolus.com
Source: Evolus
FAQ
When is Evolus (EOLS) presenting at the Needham Healthcare Conference 2025?
How long will the Evolus (EOLS) Needham Conference webcast be available for replay?
Where can investors access Evolus (EOLS) Needham Conference presentation?
What type of events will Evolus (EOLS) participate in at the Needham Healthcare Conference?
